Adjuvant interferon therapy in high-risk melanoma: For which patients? [Adjuvante Interferontherapie beim Hochrisikomelanom : Welche Patienten kommen in Frage?]

被引：0
|
作者：
Hauschild A. [1 ,2 ]
Kähler C. [1 ]
机构：
[1] Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Kiel
[2] Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, 24105 Kiel
来源：
best practice onkologie | 2007年 / 2卷 / 2期
关键词：
D O I：
10.1007/s11654-007-0014-7
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：4 / 13
页数：9
相关论文
共 50 条
  • [21] The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
    Akman, Tulay
    Oztop, Ilhan
    Baskin, Yasemin
    Akbarpour, Mahdi
    Unal, Olcun Umit
    Oflazoglu, Utku
    Ellidokuz, Hulya
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 10
  • [22] The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
    Tulay Akman
    Ilhan Oztop
    Yasemin Baskin
    Mahdi Akbarpour
    Olcun Umit Unal
    Utku Oflazoglu
    Hulya Ellidokuz
    Medical Oncology, 2015, 32
  • [23] Adjuvant high-dose interferon-α in high-risk melanoma patients:: requiem for an approval?
    Saiag, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1999, 126 (03): : 211 - 213
  • [24] The role of adjuvant interferon in high risk melanoma patients
    Sharfman, WH
    DERMATOLOGIC SURGERY, 2000, 26 (06) : 607 - 608
  • [25] Systemic adjuvant therapy for high-risk cutaneous melanoma
    Kobeissi, Iyad
    Tarhini, Ahmad A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [26] Finally, a successful adjuvant therapy for high-risk melanoma
    Balch, CM
    Buzaid, AC
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 1 - 3
  • [27] Efficacy of high-dose adjuvant interferon therapy in high-risk melanoma harboring gene mutations
    Wang, Xuan
    Mao, Li Li
    Si, Lu
    Chi, Zhihong
    Cui, Chuanliang
    Sheng, Xi Nan
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] EFFICACY OF HIGH-DOSE ADJUVANT INTERFERON THERAPY IN HIGH-RISK MELANOMA HARBORING GENE MUTATIONS
    Wang, Xuan
    Mao, Lili
    Si, Lu
    Kong, Yan
    Chi, Zhihong
    Sheng, Xinan
    Cui, Chuanliang
    Lian, Bin
    Yan, Xieqiao
    Guo, Jun
    ANTICANCER RESEARCH, 2015, 35 (07) : 4352 - 4352
  • [29] Adjuvant therapy with high-dose interferon α2b in patients with high-risk stage IIB/III melanoma
    Kirkwood, John M.
    Tarhini, Ahmad A.
    Moschos, Stergios J.
    Panelli, Monica C.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (01): : 2 - 3
  • [30] Erratum to: The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy
    Tulay Akman
    Ilhan Oztop
    Yasemin Baskin
    Mahdi Akbarpour
    Olcun Umit Unal
    Utku Oflazoglu
    Hulya Ellidokuz
    Banu Lebe
    Medical Oncology, 2015, 32
12345